Spying on cells eating habits could aid cancer diagnosis

April 07, 2019

Scientists have developed a new imaging technology to visualise what cells eat, which could aid the diagnosis and treatment of diseases such as cancer.

The team has designed chemical probes that light up when they attach to specific molecules that cells eat, such as glucose.

Researchers used microscopes to watch cells eating glucose inside live zebrafish embryos, which are transparent and easy to observe. They found the technique also worked with human cells growing in the lab.

The team says their approach could easily be adapted to look at other molecules that are important for health and disease.

All cells rely on glucose and other molecules for their survival. If a cell's eating habits change, it can be a warning sign of disease.

Researchers say the new technology could help detect tiny changes in cells' eating habits inside the body's tissues, making it easier to spot diseases sooner.

Doctors could also use the technology to monitor how patients are responding to treatment, by tracking the molecules that are eaten by healthy and diseased cells.

The study, published in the journal Angewandte Chemie, was funded by Medical Research Scotland, the Biotechnology and Biological Sciences Research Council and the European Research Council. The Royal Society and the Wellcome Trust also provided funding.

Dr Marc Vendrell, Senior Lecturer in Biomedical Imaging at the University of Edinburgh, said: "We have very few methods to measure what cells eat to produce energy, which is what we know as cell metabolism. Our technology allows us to detect multiple metabolites simultaneously and in live cells, by simply using microscopes.

"This is a very important advance to understand the metabolism of diseased cells and we hope it will help develop better therapies."
-end-


University of Edinburgh

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.